Overview

Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

Status:
Completed

Trial end date:
2015-09-01

Target enrollment:

Participant gender:

Summary

This study will evaluate the safety and efficacy of an experimental antibiotic, solithromycin, in the treatment of adult patients with community-acquired pneumonia.

Phase:

Phase 3

Details

Lead Sponsor:

Cempra Inc
Melinta Therapeutics, Inc.

Treatments:

Fluoroquinolones
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
Solithromycin